One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-10-12

AUTHORS

Goran Petrovski, Fawziya Al Khalaf, Judith Campbell, Fareeda Umer, Douha Almajaly, Manar Hamdan, Khalid Hussain

ABSTRACT

ObjectiveTo evaluate the effect of a 1-year hybrid closed-loop (HCL) system on glycemic control in children and adolescents with type 1 diabetes (T1D) previously treated with multiple daily injections (MDI). MethodsThis was a 1-year observational study, as a continuation of the previous 3 months prospective study of pediatric patients with T1D conducted at Sidra Medicine in Qatar. The study enrolled individuals aged 7–18 years with T1D > 1 year, on MDI with self-monitoring of blood glucose or continuous glucose monitoring, with no prior pump experience, and with an HbA1c level < 12.5% (< 113 mmol/mol). After the first 3 months of HCL use, patients were followed at 6, 9 and 12 months, where HbA1c was obtained and pump data were collected.ResultsAll 30 participants (age 10.24 ± 2.6 years) who initiated HCL completed 12 months of HCL system use in Auto Mode. The participants used the sensor 88.4 ± 6.5% of the time with Auto Mode usage 85.6 ± 7.4% during 12 months of HCL system use. HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). TIR (70–180 mg/dL) increased from 46.9% at baseline to 71.9% at 1 month and remained above 70% during the 12 months of HCL use.ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1 year following Auto Mode initiation. More... »

PAGES

207-213

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4

DOI

http://dx.doi.org/10.1007/s00592-020-01607-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1131624636

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33044604


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose Self-Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycemic Control", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin Infusion Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Education as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrovski", 
        "givenName": "Goran", 
        "id": "sg:person.015434126120.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015434126120.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al Khalaf", 
        "givenName": "Fawziya", 
        "id": "sg:person.01163400514.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163400514.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "Judith", 
        "id": "sg:person.015054523174.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015054523174.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Umer", 
        "givenName": "Fareeda", 
        "id": "sg:person.016316134111.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016316134111.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Almajaly", 
        "givenName": "Douha", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamdan", 
        "givenName": "Manar", 
        "id": "sg:person.013764004165.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013764004165.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar", 
          "id": "http://www.grid.ac/institutes/grid.467063.0", 
          "name": [
            "Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hussain", 
        "givenName": "Khalid", 
        "id": "sg:person.01235717730.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235717730.67"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13300-018-0436-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103901307", 
          "https://doi.org/10.1007/s13300-018-0436-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-019-01472-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124151013", 
          "https://doi.org/10.1007/s00592-019-01472-w"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-10-12", 
    "datePublishedReg": "2020-10-12", 
    "description": "ObjectiveTo evaluate the effect of a 1-year hybrid closed-loop (HCL) system on glycemic control in children and adolescents with type 1 diabetes (T1D) previously treated with multiple daily injections (MDI).\nMethodsThis was a 1-year observational study, as a continuation of the previous 3\u00a0months prospective study of pediatric patients with T1D conducted at Sidra Medicine in Qatar. The study enrolled individuals aged 7\u201318\u00a0years with T1D\u2009>\u20091\u00a0year, on MDI with self-monitoring of blood glucose or continuous glucose monitoring, with no prior pump experience, and with an HbA1c level\u2009<\u200912.5% (<\u2009113\u00a0mmol/mol). After the first 3\u00a0months of HCL use, patients were followed at 6, 9 and 12\u00a0months, where HbA1c was obtained and pump data were collected.ResultsAll 30 participants (age 10.24\u2009\u00b1\u20092.6\u00a0years) who initiated HCL completed 12\u00a0months of HCL system use in Auto Mode. The participants used the sensor 88.4\u2009\u00b1\u20096.5% of the time with Auto Mode usage 85.6\u2009\u00b1\u20097.4% during 12\u00a0months of HCL system use. HbA1c decreased from 8.2\u2009\u00b1\u20091.4% (66\u2009\u00b1\u200915.3\u00a0mmol/mol) at baseline, to 6.7\u2009\u00b1\u20090.5% (50\u2009\u00b1\u20095.5\u00a0mmol/mol) at 3\u00a0months (p\u2009=\u20090.02) and remained stable to 7.1\u2009\u00b1\u20090.6 (54\u2009\u00b1\u20096.6\u00a0mmol/mol) at 12\u00a0months (p\u2009=\u20090.02). TIR (70\u2013180\u00a0mg/dL) increased from 46.9% at baseline to 71.9% at 1\u00a0month and remained above 70% during the 12\u00a0months of HCL use.ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1\u00a0year following Auto Mode initiation.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00592-020-01607-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1008525", 
        "issn": [
          "0940-5429", 
          "1432-5233"
        ], 
        "name": "Acta Diabetologica", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "58"
      }
    ], 
    "keywords": [
      "multiple daily injections", 
      "type 1 diabetes", 
      "hybrid closed-loop system", 
      "glycemic control", 
      "daily injections", 
      "HCL use", 
      "month prospective study", 
      "one-year experience", 
      "continuous glucose monitoring", 
      "pediatric patients", 
      "prospective study", 
      "blood glucose", 
      "glycemic outcomes", 
      "observational study", 
      "first month", 
      "successful outcome", 
      "Sidra Medicine", 
      "glucose monitoring", 
      "months", 
      "HbA1c", 
      "diabetes", 
      "patients", 
      "T1D", 
      "children", 
      "adolescents", 
      "baseline", 
      "outcomes", 
      "injection", 
      "years", 
      "participants", 
      "MethodsThis", 
      "ObjectiveTo", 
      "system use", 
      "study", 
      "control", 
      "glucose", 
      "use", 
      "medicine", 
      "experience", 
      "initiation", 
      "individuals", 
      "auto mode", 
      "levels", 
      "effect", 
      "monitoring", 
      "Qatar", 
      "TIR", 
      "data", 
      "time", 
      "continuation", 
      "system", 
      "HCl", 
      "drivers", 
      "mode", 
      "closed-loop system"
    ], 
    "name": "One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes", 
    "pagination": "207-213", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1131624636"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00592-020-01607-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33044604"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00592-020-01607-4", 
      "https://app.dimensions.ai/details/publication/pub.1131624636"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_838.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00592-020-01607-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00592-020-01607-4'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      21 PREDICATES      99 URIs      89 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00592-020-01607-4 schema:about N312b50e8faa548a6abab04ff4de61738
2 N3bd9bde4f62948799a4d2b95027ad56b
3 N51269f874b514425a8dda8008c4be6a4
4 N55159c9e906c40c1af45fdbaeaf29714
5 N5ea956d41436434d8947fdd6657992ff
6 N69eaa59ba8ad4556a9f90927b7fe7083
7 N6e0f1d642c5345df92caa5af4a508f5f
8 N84c997e797ef445591410d5e449ad904
9 N873c8e3de8d34332b84d8596b8d31f13
10 N944b499444a84753a5c5422a39273cb5
11 Nb3d63eb7c81e4c0781165625a4635c14
12 Nb7887184142144d78a562abe87cd2d26
13 Nc9093bb5c2d349a1b225b160c6509b32
14 Nc92f1c3dcdb64d8b8f9e53ff59865cac
15 Ncf66782ab40a4c6793be5b0edddacfd2
16 Nd4207fdbd1ee4ebfb13223f953393a7e
17 Ne8c82484beec41488e1146499f7b688f
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author Ne07cbc65b9944465b97388937d77f343
21 schema:citation sg:pub.10.1007/s00592-019-01472-w
22 sg:pub.10.1007/s13300-018-0436-y
23 schema:datePublished 2020-10-12
24 schema:datePublishedReg 2020-10-12
25 schema:description ObjectiveTo evaluate the effect of a 1-year hybrid closed-loop (HCL) system on glycemic control in children and adolescents with type 1 diabetes (T1D) previously treated with multiple daily injections (MDI). MethodsThis was a 1-year observational study, as a continuation of the previous 3 months prospective study of pediatric patients with T1D conducted at Sidra Medicine in Qatar. The study enrolled individuals aged 7–18 years with T1D > 1 year, on MDI with self-monitoring of blood glucose or continuous glucose monitoring, with no prior pump experience, and with an HbA1c level < 12.5% (< 113 mmol/mol). After the first 3 months of HCL use, patients were followed at 6, 9 and 12 months, where HbA1c was obtained and pump data were collected.ResultsAll 30 participants (age 10.24 ± 2.6 years) who initiated HCL completed 12 months of HCL system use in Auto Mode. The participants used the sensor 88.4 ± 6.5% of the time with Auto Mode usage 85.6 ± 7.4% during 12 months of HCL system use. HbA1c decreased from 8.2 ± 1.4% (66 ± 15.3 mmol/mol) at baseline, to 6.7 ± 0.5% (50 ± 5.5 mmol/mol) at 3 months (p = 0.02) and remained stable to 7.1 ± 0.6 (54 ± 6.6 mmol/mol) at 12 months (p = 0.02). TIR (70–180 mg/dL) increased from 46.9% at baseline to 71.9% at 1 month and remained above 70% during the 12 months of HCL use.ConclusionHCL system (MiniMed 670G) in children and adolescents previously treated with MDI significantly improves glycemic outcomes (HbA1c and Time in Ranges) immediately during the first month. This improved glycemic control was maintained over the 1 year following Auto Mode initiation.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf Nb97408c20f974ea89556d0d9cdf43bd7
29 Nbbdbdf266cf642c19a0d24d2708fca95
30 sg:journal.1008525
31 schema:keywords HCL use
32 HCl
33 HbA1c
34 MethodsThis
35 ObjectiveTo
36 Qatar
37 Sidra Medicine
38 T1D
39 TIR
40 adolescents
41 auto mode
42 baseline
43 blood glucose
44 children
45 closed-loop system
46 continuation
47 continuous glucose monitoring
48 control
49 daily injections
50 data
51 diabetes
52 drivers
53 effect
54 experience
55 first month
56 glucose
57 glucose monitoring
58 glycemic control
59 glycemic outcomes
60 hybrid closed-loop system
61 individuals
62 initiation
63 injection
64 levels
65 medicine
66 mode
67 monitoring
68 month prospective study
69 months
70 multiple daily injections
71 observational study
72 one-year experience
73 outcomes
74 participants
75 patients
76 pediatric patients
77 prospective study
78 study
79 successful outcome
80 system
81 system use
82 time
83 type 1 diabetes
84 use
85 years
86 schema:name One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes
87 schema:pagination 207-213
88 schema:productId N443f7387fda440a7a71da717567d3dfd
89 N493439116148474bb5bd42b9dcaf29c0
90 Nbce00e363dbb49e69df5c5ceee4c30cc
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1131624636
92 https://doi.org/10.1007/s00592-020-01607-4
93 schema:sdDatePublished 2022-09-02T16:03
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N93217911268649fb97e292c2a34bdff4
96 schema:url https://doi.org/10.1007/s00592-020-01607-4
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N17c9ab621c514116be1df4f1a075073c schema:affiliation grid-institutes:grid.467063.0
101 schema:familyName Almajaly
102 schema:givenName Douha
103 rdf:type schema:Person
104 N312b50e8faa548a6abab04ff4de61738 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Treatment Outcome
106 rdf:type schema:DefinedTerm
107 N33f87c57a1344b799e7312abf8febf10 rdf:first sg:person.01163400514.20
108 rdf:rest Ncf2236e4a2e54d72b9e57ff4f790e5aa
109 N3bd9bde4f62948799a4d2b95027ad56b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Hypoglycemic Agents
111 rdf:type schema:DefinedTerm
112 N443f7387fda440a7a71da717567d3dfd schema:name dimensions_id
113 schema:value pub.1131624636
114 rdf:type schema:PropertyValue
115 N44bbbcc4010543a59d8848cde2774749 rdf:first sg:person.01235717730.67
116 rdf:rest rdf:nil
117 N493439116148474bb5bd42b9dcaf29c0 schema:name pubmed_id
118 schema:value 33044604
119 rdf:type schema:PropertyValue
120 N51269f874b514425a8dda8008c4be6a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Male
122 rdf:type schema:DefinedTerm
123 N55159c9e906c40c1af45fdbaeaf29714 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Patient Education as Topic
125 rdf:type schema:DefinedTerm
126 N5ea956d41436434d8947fdd6657992ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Glycemic Control
128 rdf:type schema:DefinedTerm
129 N69eaa59ba8ad4556a9f90927b7fe7083 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Insulin Infusion Systems
131 rdf:type schema:DefinedTerm
132 N6e0f1d642c5345df92caa5af4a508f5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Blood Glucose Self-Monitoring
134 rdf:type schema:DefinedTerm
135 N75a6cf675ed8455e9a43dd0da3dbd4a0 rdf:first N17c9ab621c514116be1df4f1a075073c
136 rdf:rest N7eddbb61597445279cd6001faf0ef0f0
137 N7eddbb61597445279cd6001faf0ef0f0 rdf:first sg:person.013764004165.63
138 rdf:rest N44bbbcc4010543a59d8848cde2774749
139 N84c997e797ef445591410d5e449ad904 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Diabetes Mellitus, Type 1
141 rdf:type schema:DefinedTerm
142 N873c8e3de8d34332b84d8596b8d31f13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Prospective Studies
144 rdf:type schema:DefinedTerm
145 N93217911268649fb97e292c2a34bdff4 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N944b499444a84753a5c5422a39273cb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Blood Glucose
149 rdf:type schema:DefinedTerm
150 Nb3d63eb7c81e4c0781165625a4635c14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Insulin
152 rdf:type schema:DefinedTerm
153 Nb7887184142144d78a562abe87cd2d26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Injections
155 rdf:type schema:DefinedTerm
156 Nb97408c20f974ea89556d0d9cdf43bd7 schema:volumeNumber 58
157 rdf:type schema:PublicationVolume
158 Nbbdbdf266cf642c19a0d24d2708fca95 schema:issueNumber 2
159 rdf:type schema:PublicationIssue
160 Nbce00e363dbb49e69df5c5ceee4c30cc schema:name doi
161 schema:value 10.1007/s00592-020-01607-4
162 rdf:type schema:PropertyValue
163 Nbe619ce893814941b08aca2f88412fb9 rdf:first sg:person.016316134111.19
164 rdf:rest N75a6cf675ed8455e9a43dd0da3dbd4a0
165 Nc9093bb5c2d349a1b225b160c6509b32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Drug Administration Schedule
167 rdf:type schema:DefinedTerm
168 Nc92f1c3dcdb64d8b8f9e53ff59865cac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Adolescent
170 rdf:type schema:DefinedTerm
171 Ncf2236e4a2e54d72b9e57ff4f790e5aa rdf:first sg:person.015054523174.35
172 rdf:rest Nbe619ce893814941b08aca2f88412fb9
173 Ncf66782ab40a4c6793be5b0edddacfd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Humans
175 rdf:type schema:DefinedTerm
176 Nd4207fdbd1ee4ebfb13223f953393a7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Child
178 rdf:type schema:DefinedTerm
179 Ne07cbc65b9944465b97388937d77f343 rdf:first sg:person.015434126120.67
180 rdf:rest N33f87c57a1344b799e7312abf8febf10
181 Ne8c82484beec41488e1146499f7b688f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Female
183 rdf:type schema:DefinedTerm
184 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
185 schema:name Medical and Health Sciences
186 rdf:type schema:DefinedTerm
187 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
188 schema:name Clinical Sciences
189 rdf:type schema:DefinedTerm
190 sg:journal.1008525 schema:issn 0940-5429
191 1432-5233
192 schema:name Acta Diabetologica
193 schema:publisher Springer Nature
194 rdf:type schema:Periodical
195 sg:person.01163400514.20 schema:affiliation grid-institutes:grid.467063.0
196 schema:familyName Al Khalaf
197 schema:givenName Fawziya
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163400514.20
199 rdf:type schema:Person
200 sg:person.01235717730.67 schema:affiliation grid-institutes:grid.467063.0
201 schema:familyName Hussain
202 schema:givenName Khalid
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235717730.67
204 rdf:type schema:Person
205 sg:person.013764004165.63 schema:affiliation grid-institutes:grid.467063.0
206 schema:familyName Hamdan
207 schema:givenName Manar
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013764004165.63
209 rdf:type schema:Person
210 sg:person.015054523174.35 schema:affiliation grid-institutes:grid.467063.0
211 schema:familyName Campbell
212 schema:givenName Judith
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015054523174.35
214 rdf:type schema:Person
215 sg:person.015434126120.67 schema:affiliation grid-institutes:grid.467063.0
216 schema:familyName Petrovski
217 schema:givenName Goran
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015434126120.67
219 rdf:type schema:Person
220 sg:person.016316134111.19 schema:affiliation grid-institutes:grid.467063.0
221 schema:familyName Umer
222 schema:givenName Fareeda
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016316134111.19
224 rdf:type schema:Person
225 sg:pub.10.1007/s00592-019-01472-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1124151013
226 https://doi.org/10.1007/s00592-019-01472-w
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s13300-018-0436-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1103901307
229 https://doi.org/10.1007/s13300-018-0436-y
230 rdf:type schema:CreativeWork
231 grid-institutes:grid.467063.0 schema:alternateName Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar
232 schema:name Division of Endocrinology and Diabetes, Department of Pediatric Medicine, Sidra Medicine, HB 6E 219, Al Luqta Street, Education City North Campus, PO Box 26999, Doha, Qatar
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...